• 1
    El-Diasty TA, El-Ghar ME, Shokeir AA et al. Magnetic resonance imaging as a sole method for the morphological and functional evaluation of live kidney donors. BJU Int 2005; 96: 1116
  • 2
    Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate. Eur J Nucl Med 1995; 22: 137984
  • 3
    Eshima D, Taylor A Jr. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent. Semin Nucl Med 1992; 22: 6173
  • 4
    Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 1984; 66: 6139
  • 5
    Picciotto G, Cacace G, Cesana P, Mosso R, Ropolo R, De Filippi PG. Estimation of chromium-51 ethylene diamine tetra-acetic acid plasma clearance: a comparative assessment of simplified techniques. Eur J Nucl Med 1992; 19: 305
  • 6
    Piepsz A, Kinthaert J, Gordon I et al. Improving the accuracy of 99Tcm-mercaptoacetyltriglycine clearance by using two blood samples instead of one? Paediatric Task Group of the EANM. Nucl Med Commun 1994; 15: 52932
  • 7
    Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens 1999; 17: 30917